Agilent Technologies Inc
NYSE:A
Agilent Technologies Inc
NYSE:A
Price:
132.73 USD
0.22%
Market Closed
Updated:
Apr 20, 2024
Agilent Technologies Inc
Capital Expenditures
Last
Value
3-Years CAGR
5-Years CAGR
|
Agilent Technologies Inc
Capital Expenditures Peer Comparison
Comparables:
TMO
DHR
WST
MTD
IQV
Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Agilent Technologies Inc
NYSE:A
|
Capital Expenditures
$-312m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-6%
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Capital Expenditures
$-1.5B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-18%
|
|
|
Danaher Corp
NYSE:DHR
|
Capital Expenditures
$-1.4B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-10%
|
|
|
West Pharmaceutical Services Inc
NYSE:WST
|
Capital Expenditures
$-362m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
-9%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Capital Expenditures
$-105.3m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
6%
|
CAGR 10-Years
-2%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Capital Expenditures
$-649m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-22%
|
See Also
What is Agilent Technologies Inc's Capital Expenditures?
Capital Expenditures
-312m
USD
-312m
USD
Based on the financial report for Jan 31, 2024, Agilent Technologies Inc's Capital Expenditures amounts to -312m USD.
What is Agilent Technologies Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-6%
-6%
Over the last year, the Capital Expenditures growth was -7%. The average annual Capital Expenditures growth rates for Agilent Technologies Inc have been -35% over the past three years , -15% over the past five years , and -6% over the past ten years .
You don't have any saved screeners yet
